Established August 2000
Canadian Non Profit, Non Share Corporation
Date of Letters Patent - January 15, 2001
Board of Directors:
July 1, 2019 to June 30, 2023
- Laurence Klotz, MD - Chairman
Directors:
- Dr. Larry Goldenberg (West): Vice-Chaiman
- Dr. Darryl Drachenberg (West)
- Dr. Dean Elterman (Ontario)
- Dr. Robert Hamilton (Ontario): Secretary-Treasurer
- Dr. Rob Siemens (Ontario)
- Dr. Anil Kapoor (Ontario)
- Dr. Vincent Fradet (Quebec)
- Dr. Ricardo Rendon (Atlantic)
Ex-Officio Board Members:
Management Consultant:
Executive Assistant:
Marlene Kebabdjian
Membership:
Over 120 urologists
Clinical Trial Sites:
Over 80
Sources of Funding:
- Client Sponsor Agreements
Cooperative Alliances:
- Canadian Urological Association
- Canadian Uro-Oncolgy Group
General Liability Insurance:
- Health Insurance Reciprocal of Canada (HIROC)
Auditors:
Campbell Lawless Chartered Accountants
Legal Counsel:
Enfield Wood
CURC CLIENTS:
- Abbott Laboratories Limited
- AbbVie
- Astellas
- Astra Zeneca Canada Inc.
- CMX Research Inc.
- Dendreon Corporation
- Ferring Inc.
- GlaxoSmithKline
- Merck Frosst Canada Ltd.
- Sanofi - Synthelabo Canada Inc.
- Spectrum Pharmaceuticals Inc.
- Viventia Biotech Inc.
- Ontario Institute of Cancer Research